On August 29, 2024 UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, reported that it will participate in fireside chats at the following investor conferences in September (Press release, UroGen Pharma, AUG 29, 2024, View Source [SID1234646212]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 26th Annual Global Investment Conference – September 9-11th, 2024
Fireside Chat: September 9th, 2024 at 9:00am ET
Location: New York, NY
Webcast Registration Link: Here

2024 Cantor Global Healthcare Conference – September 17-19th, 2024
Fireside Chat: September 18, 2024 at 3:40pm ET
Location: New York, NY
Webcast Registration Link: Here

A webcast from the conference will also be available via the Investors section of UroGen’s website, www.urogen.com. A replay of the webcast will be available for approximately 90 days.